These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 60886)

  • 21. Serum alpha-fetoprotein response as a surrogate for clinical outcome in patients receiving systemic therapy for advanced hepatocellular carcinoma.
    Vora SR; Zheng H; Stadler ZK; Fuchs CS; Zhu AX
    Oncologist; 2009 Jul; 14(7):717-25. PubMed ID: 19581525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of chemotherapeutic agents on alpha-fetoprotein secretion and growth of human hepatoma cell lines in vitro.
    Muraoka A; Tokiwa T; Sato J
    Br J Cancer; 1989 Apr; 59(4):569-72. PubMed ID: 2469455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathologic significance of protein induced vitamin K absence or antagonist II and alpha-fetoprotein in hepatocellular carcinoma.
    Nakagawa T; Seki T; Shiro T; Wakabayashi M; Imamura M; Itoh T; Tamai T; Nishimura A; Yamashiki N; Matsuzaki K; Sakaida N; Inoue K; Okamura A
    Int J Oncol; 1999 Feb; 14(2):281-6. PubMed ID: 9917503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A phase 2 study of cisplatin in patients with hepatocellular carcinoma.
    Okada S; Okazaki N; Nose H; Shimada Y; Yoshimori M; Aoki K
    Oncology; 1993; 50(1):22-6. PubMed ID: 7678453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical effects of intra-arterial infusion chemotherapy with cisplatin, mitomycin C, leucovorin and 5-flourouracil for unresectable advanced hepatocellular carcinoma.
    Lin CP; Yu HC; Cheng JS; Lai KH; Lo GH; Hsu PI; Lin CK; Chen HH; Lo CC; Liang HL; Tseng HH
    J Chin Med Assoc; 2004 Dec; 67(12):602-10. PubMed ID: 15779483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Successful treatment for advanced hepatocellular carcinoma by hepatic arterial infusion of CDDP powder as second-line chemotherapy].
    Gen Y; Kimura H; Akitake R; Sakai A; Fukui A; Takao T; Ikezawa S; Masuda A; Takashima H; Funatsu E; Nakamura H; Okuyama Y; Arai M; Yagi N; Kutsumi H; Fujimoto S; Takeuchi Y
    Gan To Kagaku Ryoho; 2006 Apr; 33(4):505-8. PubMed ID: 16612162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of Outcome of Hepatic Arterial Infusion Chemotherapy in Patients with Advanced Hepatocellular Carcinoma by the Combination of RECIST and Tumor Markers.
    Hatooka M; Kawaoka T; Aikata H; Honda F; Nakamura Y; Nakano N; Morio K; Fukuhara T; Kobayashi T; Nagaoki Y; Tsuge M; Hiramatsu A; Imamura M; Kawakami Y; Awai K; Chayama K
    Hiroshima J Med Sci; 2016 Sep; 65(2):25-33. PubMed ID: 29989682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pilot Study of Hepatic Arterial Infusion Chemotherapy with Interferon-beta and 5-fluorouracil: A New Chemotherapy for Patients with Advanced Hepatocellular Carcinoma.
    Shakado S; Iwata K; Tsuchiya N; Kunimoto H; Yotsumoto K; Fukunaga A; Kuno S; Tanaka T; Sakurai K; Iwashita H; Hirano G; Yokoyama K; Morihara D; Nishizawa S; Takeyama Y; Irie M; Sohda T; Kora S; Yoshimitsu K; Sakisaka S
    Hepatogastroenterology; 2014 May; 61(131):557-62. PubMed ID: 26176035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alpha Fetoprotein: An index of progression or regression of hepatoma, and a target for immunotherapy.
    Parks LC; Baer AN; Pollack M; Williams GM
    Ann Surg; 1974 Oct; 180(4):599-605. PubMed ID: 4137530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Time courses of PIVKA-II and AFP levels after hepatic artery embolization and hepatic artery infusion against hepatocellular carcinoma: relation between the time course and tumor necrosis.
    Kishi K; Sonomura T; Mitsuzane K; Nishida N; Kimura M; Satoh M; Yamada R; Kodama N; Kinoshita M; Tanaka H
    Radiat Med; 1992; 10(5):189-95. PubMed ID: 1279748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic arterial infusion for liver metastases from colon cancer: comparison of mitomycin C(NSC-26980) and 5-fluorouracil (NSC-19893).
    Fortuny IE; Theologides A; Kennedy BJ
    Cancer Chemother Rep; 1975; 59(2 Pt 1):401-4. PubMed ID: 1097098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Alpha-fetoprotein. Significance and current importance].
    Hirsch-Marie H; Caroli J
    Ann Med Interne (Paris); 1975 Feb; 126(2):81-6. PubMed ID: 59565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New utility of an old marker: serial alpha-fetoprotein measurement in predicting radiologic response and survival of patients with hepatocellular carcinoma undergoing systemic chemotherapy.
    Chan SL; Mo FK; Johnson PJ; Hui EP; Ma BB; Ho WM; Lam KC; Chan AT; Mok TS; Yeo W
    J Clin Oncol; 2009 Jan; 27(3):446-52. PubMed ID: 19064965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunochemical determination of alpha-fetoprotein in the dynamics of development of liver cirrhosis and hepatocellular cancer].
    Afanas'eva KA; Ragozin IuE; Tatarinov IuS
    Vestn Akad Med Nauk SSSR; 1975; (6):71-3. PubMed ID: 58499
    [No Abstract]   [Full Text] [Related]  

  • 35. Hepatocellular carcinoma responding to chemotherapy with 5-FU.
    Yoshida H; Onda M; Tajiri T; Umehara M; Mamada Y; Taniai N; Kaneko M; Mizuguchi Y; Uchida E; Yamashita K; Uchida E
    Hepatogastroenterology; 2000; 47(34):1120-1. PubMed ID: 11020893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early Decreases in α-Fetoprotein and Des-γ-carboxy Prothrombin Predict the Antitumor Effects of Hepatic Transarterial Infusion Chemotherapy with Cisplatin (CDDP) Powder in Patients with Advanced Hepatocellular Carcinoma.
    Hatanaka T; Kakizaki S; Shimada Y; Takizawa D; Katakai K; Yamazaki Y; Sato K; Kusano M; Yamada M
    Intern Med; 2016; 55(16):2163-71. PubMed ID: 27522991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Corelation of serum alpha fetoprotein and tumor size in hepatocellular carcinoma.
    Abbasi A; Bhutto AR; Butt N; Munir SM
    J Pak Med Assoc; 2012 Jan; 62(1):33-6. PubMed ID: 22352098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A complete response to one-shot hepatic arterial infusion of epirubicin in a patient with highly advanced hepatocellular carcinoma].
    Takamatsu M; Matsuda T; Kawaguchi K; Ku Y
    Gan To Kagaku Ryoho; 2007 Nov; 34(12):2102-4. PubMed ID: 18219912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma providing a good QOL].
    Yamashita S; Niinobu T; Nakagawa S; Amano M; Nishikawa Y; Hayashida H; Higaki N; Fujita M; Sakon M
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1928-30. PubMed ID: 17212149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. On the diagnostic value of alpha-1-fetoprotein (AFP) in hepatocellular carcinoma.
    Zeana C; Macarie C
    Acta Med Pol; 1976; 17(2):159-3. PubMed ID: 59516
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.